Autism spectrum disorder represents a range of neurodevelopmental conditions often accompanied by epilepsy or intellectual disability. These disorders manifest through brain alterations established during the earliest stages of development, typically becoming clinically evident in early childhood and persisting throughout life. Despite the immense genetic heterogeneity of ASD, one challenging question has persisted: Do these myriad genetic abnormalities funnel into common biological disruptions during brain development, or do they create unique, gene-specific pathologies?

To unravel this, Novarino and her collaborators embarked on an ambitious endeavor. They undertook a comprehensive analysis across diverse genetic models of ASD, focusing on high-risk genes that have been strongly implicated in the disorder. Their aim was to identify whether the molecular cascades impacted by distinct mutations converge on shared cellular pathways or diverge into discrete, mutation-specific signatures. This question required an unprecedented scale of molecular data collection and integration.

Technological advances in multi-omics sequencing have made it possible to generate such detailed datasets. The team harnessed “single-nucleus multi-omics sequencing,” a sophisticated technique that permits simultaneous interrogation of multiple layers of nuclear information from individual cells. This method encompasses not only genomic sequences but also transcriptomic profiles—reflecting which genes are actively expressed—and epigenomic modifications that regulate gene activity without altering the underlying DNA code. This multi-dimensional approach enables researchers to dissect the intricate regulatory architecture within each nucleus with unprecedented resolution.

By examining over 250 samples derived from two functionally distinct brain regions in both male and female mice at various developmental stages, the research team achieved a panoramic view of neurodevelopmental changes prompted by ASD-linked mutations. Their data revealed a remarkable convergence: different genetic mutations ultimately affected overlapping cortical cell types and molecular processes during critical windows of brain maturation. These shared perturbations centered on transient delays in neuronal differentiation and synaptic connectivity, rather than permanent cellular defects.

Intriguingly, the study also illuminated sex-specific responses to ASD-associated genetic changes. Female mice exhibited distinct molecular and activity-dependent alterations compared to males, suggesting that biological sex modulates the trajectory of ASD pathophysiology. Such findings underscore the necessity for precision medicine paradigms that account for sex as a fundamental biological variable in autism intervention strategies.

Although the mutations induced shared effects on brain development, each genetic model bore unique molecular fingerprints, highlighting the heterogeneity beneath the surface convergence. This duality—common developmental disruptions intersecting with mutation-specific signatures—illustrates the complexity researchers face when designing therapeutic approaches for ASD. Not all interventions will be universally effective; instead, treatments must be contextualized within an individual’s genetic background, biological sex, and stage of neurodevelopment.

The transient nature of many observed abnormalities is particularly noteworthy. The molecular delays in neural maturation and connectivity, which diminish approximately two weeks postnatally in mouse models, hint at critical windows for therapeutic intervention. Early-stage modulation of these developmental pathways might correct or compensate for aberrant trajectories before they solidify into chronic dysfunction. This temporal aspect suggests that the timing of treatment administration is as critical as its molecular target.

Furthermore, the integration of molecular and physiological data revealed that alterations in brain activity paralleled the molecular signatures, providing functional validation of the observed molecular perturbations. This linkage between genotype, molecular phenotype, and electrophysiological effect forms a robust platform for future studies targeting neural circuit function in ASD.

The implications of this work extend beyond the confines of autism research. It enhances the broader understanding of human cortical development, shedding light on how diverse genetic insults can disrupt the delicate choreography of neurogenesis and circuit assembly. The study exemplifies the power of combining advanced sequencing technologies with rigorous developmental neuroscience to decode the complexity of brain disorders.

Moving forward, the Novarino group advocates for therapeutic strategies that are tailored not only to specific genetic causes but also to the developmental timing and sex of the individual. This multidimensional approach challenges the conventional one-size-fits-all paradigm and promotes personalized medicine founded on a precise understanding of the biological landscape unique to each patient’s autism.

Autism affects millions worldwide, impacting families across every culture and community. The insights from this seminal study represent a significant leap toward demystifying ASD’s biological roots. By revealing the nuances of brain development altered by different mutations, the research brings the field closer to developing timely, targeted interventions that can improve the quality of life for affected individuals.

The continued integration of single-cell multi-omics and functional neuroscience promises to yield deeper insights into the dynamic processes that sculpt the developing brain. By harnessing these cutting-edge tools, researchers can chart the complex interplay of genetic and epigenetic factors that culminate in ASD, ultimately driving innovative solutions for diagnosis and therapy.

In sum, this research exemplifies how modern molecular tools can unravel the layered complexity of neurodevelopmental disorders. It marks a critical step toward understanding autism not as a monolithic condition but as a constellation of biological phenomena intertwined through common developmental pathways and individualized molecular signatures. As the scientific community takes up the challenge of translating these findings into clinical applications, the future holds promise for more effective, personalized approaches to autism care that embrace the disorder’s inherent diversity.

Subject of Research: The molecular and cellular mechanisms underpinning autism spectrum disorder using mouse models to study cortical development dynamics.

Article Title: Cortical development dynamics across autism spectrum disorder mouse models.

News Publication Date: 17 June 2026

Web References:
DOI: 10.1038/s41586-026-10679-1

Image Credits: © Mohammad Goudarzi / ISTA

Keywords

Autism, Autism Spectrum Disorder, ASD, Neurodevelopmental Disorders, Cortical Development, Single-Nucleus Sequencing, Multi-Omics, Epigenetics, Genetics, Mouse Models, Neuroscience, Brain Development, Neurogenetics, Developmental Neuroscience

Maternal hypothyroidism during pregnancy has long been implicated in adverse neurodevelopmental outcomes in children, but the mechanisms linking maternal thyroid dysfunction to autism have remained elusive. This study bridges that gap by focusing specifically on subclinical hypothyroidism, a condition characterized by subtly reduced thyroid function that often goes undiagnosed yet may exert profound effects on fetal brain development. Using rodent models, the researchers meticulously dissected the behavioral and molecular alterations driven by maternal SCH, illuminating a direct pathway through which thyroid insufficiency cascades into autism-like phenotypes.

At the center of their findings lies the Wnt/BDNF axis, a critical neurodevelopmental signaling pathway known for its roles in neural proliferation, differentiation, and synaptic plasticity. The Wnt proteins regulate a plethora of developmental processes, while brain-derived neurotrophic factor (BDNF) serves as a key neurotrophic factor essential for synaptic maturation and cognitive functions. Disruption in Wnt or BDNF signaling has been consistently linked with neurodevelopmental disorders, making this pathway a focal point for potential interventions.

The study revealed that maternal SCH induced a significant downregulation of Wnt signaling components in the offspring’s brain, particularly in the hippocampus and prefrontal cortex—regions intimately involved in cognition, social behavior, and emotional regulation. Correspondingly, BDNF expression was markedly reduced, suggesting that impaired neurotrophic support compromises synaptic integrity and neural network formation. These molecular changes dovetailed with behavioral abnormalities that mirror core features of autism, including social interaction deficits, increased repetitive behaviors, and heightened anxiety-like responses.

Behavioral assays corroborated the molecular data, with offspring of SCH-affected mothers displaying notable impairments in social novelty preference tests and elevated self-grooming behaviors, both well-established indicators of autism-like phenotypes in rodent models. The anxiety-related phenotype was further substantiated by increased thigmotaxis during open field testing, reflecting heightened stress and altered emotional processing. Importantly, these behavioral features were absent or significantly attenuated in control groups, emphasizing the specificity of the maternal SCH effect.

Underpinning these functional disturbances, synaptic ultrastructure analyses via electron microscopy unveiled pronounced deficits in dendritic spine density and morphology in cortical neurons of SCH offspring. The observed reduction in mature, mushroom-shaped spines points to weakened synaptic connectivity, a hallmark observed in multiple ASD models. These synaptic impairments elucidate the structural basis for disrupted neural circuits that underlie the observed behavioral deficits.

Molecular assays further delineated the mechanism, highlighting a cascade wherein maternal SCH perturbs canonical Wnt signaling, leading to diminished transcriptional activation of BDNF. This downregulated BDNF expression compromises neuronal survival and plasticity during critical developmental windows, ultimately translating to long-lasting neurobehavioral consequences. The study’s data suggest a direct link between thyroid hormone insufficiency, Wnt pathway dysregulation, and subsequent neurotrophic deficits.

Intriguingly, the investigators also explored downstream mediators, noting alterations in glycogen synthase kinase 3 beta (GSK-3β) activity—a key kinase negatively regulating Wnt signaling. Elevated GSK-3β phosphorylation status in SCH offspring brains implicates its involvement as a modulatory node influencing both Wnt and BDNF pathways. Targeting GSK-3β pharmacologically could therefore represent a viable therapeutic strategy to restore signaling balance and mitigate neurodevelopmental impairment.

The translational implications of these findings are profound. Subclinical hypothyroidism, often overlooked in prenatal care, may silently predispose offspring to neurodevelopmental challenges that manifest as ASD phenotypes. Early identification and intervention targeting the Wnt/BDNF axis might offer new avenues to prevent or ameliorate such outcomes. The study advocates for heightened vigilance in maternal thyroid screening and suggests that adjunct therapies modulating Wnt and neurotrophic signaling hold therapeutic promise.

Moreover, the work advances a mechanistic framework that integrates endocrine disruptions with neural circuit malformations characteristic of autism, moving beyond correlative studies to molecular causality. This rigorous mechanistic elucidation paves the way for biomarker development and targeted treatments that could significantly improve quality of life for affected individuals.

The authors also stress the need for further research to validate these findings in human populations and to explore the therapeutic potential of modulating Wnt/BDNF signaling in clinical contexts. They propose future studies employing genetic and pharmacological tools to precisely manipulate these pathways during critical prenatal and early postnatal periods, aiming to reverse or mitigate autism-like phenotypes.

Additionally, this research highlights the broader significance of maternal health on offspring neurodevelopment, underscoring that even mild maternal endocrine anomalies can have lasting neurobiological consequences. This insight stresses the importance of comprehensive prenatal monitoring and suggests revisiting current guidelines surrounding thyroid function assessments in pregnancy.

Beyond the immediate scope of autism, the elucidated Wnt/BDNF dysregulation may also intersect with other neuropsychiatric conditions linked to maternal thyroid dysfunction, including anxiety disorders and cognitive impairments. Thus, the study opens a wider dialogue on maternal-fetal health interactions and their impacts on long-term neurological outcomes.

The utilization of sophisticated molecular techniques, behavioral paradigms, and ultrastructural analyses in this study represents a benchmark for neurodevelopmental research, demonstrating how multidisciplinary approaches can unravel complex pathophysiologies. The integration of in vivo rodent models with molecular assays delivers a compelling narrative from gene regulation to behavior—a crucial framework for modern neuroscience.

In summary, this pioneering research unearths a critical role for the Wnt/BDNF pathway in mediating maternal SCH-induced autism-like phenotypes in offspring rats. By unraveling the molecular and behavioral sequelae of thyroid hormone insufficiency, it offers novel insights into the developmental origins of ASD and highlights promising molecular targets for intervention.

As autism’s global prevalence continues to rise, insights such as these emphasize the imperative for early diagnosis, prevention, and tailored therapies grounded in a deep understanding of neurobiology. This study thus heralds a new chapter in unraveling the intricate dance between endocrine health and brain development, bringing the scientific community closer to unmasking autism’s enigmatic origins and ultimately improving clinical outcomes.

Subject of Research: Maternal subclinical hypothyroidism-induced autism-like phenotypes in offspring rats and the role of the Wnt/BDNF signaling pathway.

Article Title: The role of the Wnt/BDNF pathway in maternal SCH-induced autism-like phenotypes in offspring rats: behavioral and molecular mechanisms.

Article References:
Liu, D., Tao, K., Sun, Y. et al. The role of the Wnt/BDNF pathway in maternal SCH-induced autism-like phenotypes in offspring rats: behavioral and molecular mechanisms. Transl Psychiatry 15, 387 (2025). https://doi.org/10.1038/s41398-025-03570-6

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03570-6